Jonathan S. Lewin named CEO at Emory Healthcare, leaves Johns Hopkins
Jonathan S. Lewin, MD, senior vice president for integrated healthcare delivery and co-chair for strategic planning at Johns Hopkins Medicine, will leave the Baltimore health system for Emory Healthcare in Atlanta. He is slated to begin his tenure as president, CEO and chairman of the board of directors at Emory on Feb. 1.
Lewin also will serve as executive director for Emory's Woodruff Health Sciences Center.
"It is exciting to join the outstanding faculty and staff of Emory's Woodruff Health Sciences Center and Emory Healthcare in educating tomorrow's healthcare workforce, pursuing discovery and innovation in the health sciences, and providing skilled and compassionate care to our patients," Lewin said in a statement.
[See also: Running list: Notable hires, promotions in health IT.]
Lewin joins Emory with an "impressive track record of innovative and high-impact research, exceptional patient care and visionary administrative acumen," said Emory President James W. Wagner. "His insights as a leader, clinician and researcher will benefit our patients, faculty, students and staff, as well as the state of Georgia and beyond."
Lewin's appointment to Emory Healthcare follows an extensive national search, Emory leaders said
[Like Healthcare IT News on Facebook]
At Johns Hopkins, Lewin also serves as professor and chair of the Russell H. Morgan Department of Radiology and Radiological Science at Johns Hopkins University as well as the radiologist-in-chief at Johns Hopkins Hospital, with secondary appointments as professor of oncology, neurosurgery and biomedical engineering.
Before joining Johns Hopkins, Lewin was the director of the Division of Magnetic Resonance Imaging and vice chairman for research and academic affairs in the Department of Radiology at Case Western Reserve University and the University Hospitals of Cleveland.
Lewin is internationally recognized as a pioneer in interventional and intraoperative magnetic resonance imaging. He has developed more than 20 patents.